M. Fopp

Evidence for persistence of human parvovirus B19 DNA in bone marrow

P. Cassinotti, G. Burtonboy, M. Fopp et al. · Journal of Medical Virology · 1997 · 160 citations

Diagnostic Virology, Viral Persistence, Molecular Virology +12

Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma

Ying Waeckerle‐Men, Edith Uetz‐von Allmen, M. Fopp et al. · Cancer Immunology Immunotherapy · 2006 · 118 citations · Full text

Cancer Immunosurveillance, Immunology, Hormone-refractory Prostate Carcinoma +4

ACUTE MYELOGENOUS LEUKAEMIA: MAINTENANCE CHEMOTHERAPY AFTER EARLY CONSOLIDATION TREATMENT DOES NOT PROLONG SURVIVAL

Chr. Sauter, M. Fopp, Paul Imbach et al. · The Lancet · 1984 · 117 citations

Hematological Malignancy, Oncology, Acute Myelogenous Leukaemia +8

Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK)

Christoph Rochlitz, Andreas Lohri, M. Bacchi et al. · Leukemia · 1999 · 111 citations

Hematological Malignancy, Tumor Biology, Swiss Group +11

Mutation analysis of the N‐<i>ras</i> proto‐oncogene in active and remission phase of human acute leukemias

Hans‐Peter Senn, Ch. Trǎn‐Thang, A Wodnar-Filipowicz et al. · International Journal of Cancer · 1988 · 49 citations